MOLLY KIDNEY: Open Payments
NPI 1538655212 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$555 in 31 payments from 7 companies in 2025. Trend: 2023 $1,016 · 2024 $674 · 2025 $555
Food & beverage: $555
| Company | Payments | Amount |
|---|---|---|
| Biogen, Inc. | 13 | $228 |
| Astellas Pharma US Inc | 8 | $155 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $71 |
| Hologic Sales and Service, LLC | 2 | $39 |
| Dexcom, Inc. | 1 | $24 |
| CooperSurgical, Inc. | 1 | $20 |
| Exeltis, USA Inc. | 1 | $18 |
Products named: ZURZUVAE, Veozah, Mirena, Dexcom G6 Transmitter, NOVASURE, Paragard T 380A, SLYND, ACESSA PROVU SYSTEM.
Industry payments across IN — which companies pay providers there.
